You are right but, your point is?Regardless, the pathologist is the responsible 
for his/her diagnosis/interpretation and the liability is his/hers.Remember 
that for us histotechs, our "client" is the pathologist (always remembering the 
patient behind the whole process) and our essential duty is to provide the 
pathologist what s/he needs to being able to make the best and more accurate 
diagnosis.Follow his/her instructions and your life will be much simpler and 
less stressful.René 

    On Tuesday, November 21, 2017 4:21 PM, "Lindrud, Scott via Histonet" 
<histonet@lists.utsouthwestern.edu> wrote:
 

 Hi All,

We are having an internal debate regarding Her2 IHC control tissue in our lab.  
We run a MTA (multi tissue array) consisting of 0+, 1+, 2+, and 3+ Her2 
staining tissue taken from lumpectomy/resection cases.  I'm in the process of 
searching for more tissue to use in future control blocks and it can be 
difficult to find tissue that is 0+ and 3+.

I've discussed this with our pathologist in charge of Histology and he says 
that we don't need to run all 4 of the cores as controls.  He says all we need 
to run is a positive control and a negative control.  He says the positive 
control could be a 2+ or 3+ and the negative control could be either a 0+ OR a 
1+.

I respectfully disagreed with him and said the negative control is not meant 
for accessing staining interpretation but to verify the sensitivity and 
specificity of the actual antibody-antigen reaction.  I said a 1+ is still 
staining the tissue where there is no staining in a 0+ reaction.  The 1+ is not 
a negative staining reaction, but a negative interpretation.  The pathologist 
says I'm wrong.

The CAP in its checklist says "It is also important to assess the specificity 
of each antibody by a negative tissue control, which must show no staining of 
tissues known to lack the antigen".    To me, a 1+ Her2 staining reaction shows 
that that tissue has antigen and should not be used as a negative control.

So, after saying all that, can/should  1+ Her2 breast tissue be used as a 
negative tissue control?  Seems pretty straight forward to me, but I'm just a 
Cytotechnologist/Histotech.

Thanks for any input!

Scott

Scott A. Lindrud, MLS(ASCP)CM CTCM
Histopathology Technical Specialist/Cytotechnologist
Rice Memorial Hospital
301 Becker Ave SW
Willmar, MN 56201
WP(320)231-4406
Fax(320)231-4861
scott.lind...@rice.willmar.mn.us


________________________________

"This e-mail transmission is for the sole use of the intended recipient(s) and 
may contain confidential and privileged information. Any unauthorized review, 
use, disclosure, or distribution violates confidentiality and privacy laws and 
is prohibited. If you are not the intended recipient, please notify the sender 
immediately and delete all copies of the message. Thank you."
_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


   

|  | Virus-free. www.avast.com  |

_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

Reply via email to